ACTRN12615000832572已完成1 期
A single dose, randomized, blinded, bioequivalence study of 50 mg desvenlafaxine extended release tablets in a 2 way crossover comparison against the innovator 50 mg desvenlafaxine extended release tablet conducted under fasting conditions in healthy male and female volunteers
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 55 Years（—）
- 性别
- All
入选标准
- •Healthy males and Females
- •Aged between 18 and 55
- •Non-smoker
- •BMI between 18 and 33
- •Normal, healthy individuals as determined by medical history, physical examination, ECG, blood pressure and laboratory tests
- •Able to provide written informed consent
排除标准
- •Any history of recent recurrent attacks of bronchitis, asthma, migraine headaches
- •Concomitant drug therapy of any kind (excluding prescribed hormonal contraceptives
- •History of depression, anxiety, obsessive-compulsive disorder, or post-traumatic stress syndrome
- •Pregnant or breast-feeding
- •Sensitivity to desvenlafaxine, any antidepressant agens, excipients of desvenlafaxine
- •History of any conditions that might interfere with the absorption, distribution, metabolism or excretion of the drug
- •Smoker (anyone who has smoked in the last 6 months)
- •History of alcohol or drug abuse or dependency
- •Participation in a drug study within 60 days of the start of the study or donated blood in the 60 days preceding the study.
- •Volunteers for whom the Clinical Investigator believes, for any reason, that participation would not be an acceptable risk.
研究者
相似试验
已完成
1 期
Comparative assessment of the absorption of a generic formulation of clobazam suspension against the innovator clobazam suspension conducted under fed conditions in healthy male and female volunteersACTRN12616001418460Zenith Technology Corp Ltd34
已完成
1 期
Comparative assessment of the absorption of a generic formulation of 50 mg quetiapine prolonged release tablet against the innovator 50 mg quetiapine tablet conducted under fasting conditions in healthy male and female volunteers.Bioequivalence study conducted in healthy volunteers comparing two formulations of quetiapine with no health condition or problem studied. Although this study is being conducted in healthy volunteers who are not being treated for the condition to which the medicine is used, quetiapine belongs to a class of medicines called an atypical antipsychotic drug and is prescribed for the maintenance treatment of Bipolar and schizophrenia.Bioequivalence study conducted in healthy volunteers comparing two formulations of quetiapine with no health condition or problem studied.Although this study is being conducted in healthy volunteers who are not being treated for the condition to which the medicine is used, quetiapine belongs to a class of medicines called an atypical antipsychotic drug and is prescribed for the maintenance treatment of Bipolar and schizophrenia.Other - Research that is not of generic health relevance and not applicable to specific health categories listed aboveACTRN12613001133729Zenith Technology Corporation Limited44
已完成
1 期
Comparative assessment of the absorption of a generic formulation of metformin XR tablet against the innovator metformin SR prolonged release tablet conducted under fed conditions in healthy male and female volunteersACTRN12615000139572Zenith Technology Corp Ltd24
已完成
1 期
Comparative assessment of the absorption of a generic formulation of fingolimod capsule against the innovator fingolimod capsule conducted under fed conditions in healthy male and female volunteersACTRN12614000599673Zenith Technology Corporation Limited26
已完成
1 期
Comparative assessment of the absorption of a generic formulation of levonorgestrel tablet against the innovator levonorgestrel tablet conducted under fasting conditions in healthy female volunteersACTRN12613001123730Zenith Technology Corp Ltd24